Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNTech SE - ADR (BNTX) vs Taiwan Semiconductor Mfg. Co. Ltd. (TSM) Price & Performance

BioNTech SE - ADRTrade
Taiwan Semiconductor Mfg. Co. Ltd.Trade

Price performance (Past 24H)

Key statistics

BioNTech SE - ADR vs Taiwan Semiconductor Mfg. Co. Ltd. — how do they compare? BioNTech SE - ADR trades at $89.8 (market cap $22.86B), while Taiwan Semiconductor Mfg. Co. Ltd. trades at $421.34 (market cap $1.96T). The key difference: Taiwan Semiconductor Mfg. Co. Ltd. is far larger — about 85.7× BioNTech SE - ADR's market cap, and Taiwan Semiconductor Mfg. Co. Ltd. pays a 0.9% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.

BNTXTSM
Market Cap
$22.86B$1.96T
Sector
HealthTechnology
52-Week High
$119.34$477.57
52-Week Low
$83.89$227.33
Enterprise Value
$6.53B$1.89T
Dividend Yield
0.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BioNTech SE - ADR

No Aura AI signal available yet.

Taiwan Semiconductor Mfg. Co. Ltd.

TSM trades at $421.58, down 2.89% on the day, with a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 results expected soon. Revenue grew to $3.81 trillion in 2025, with a net income margin of 46.5%. Analysts maintain a strong buy consensus with a $493.75 price target, citing AI-driven demand.

Outlook remains positive due to robust AI chip demand and earnings momentum, but risks include geopolitical tensions and high valuation multiples. The stock offers growth potential with support from institutional sentiment, though near-term volatility may persist around earnings.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX

About Taiwan Semiconductor Mfg. Co. Ltd.

Taiwan Semiconductor Manufacturing Company, or TSMC, is the world's largest dedicated chip foundry, with over 57% market share in 2021 per Gartner. TSMC was founded in 1987 as a joint venture of Philips, the government of Taiwan, and private investors. It went public as an ADR in the U.S. in 1997. TSMC's scale and high-quality technology allow the firm to generate solid operating margins, even in the highly competitive foundry business. Furthermore, the shift to the fabless business model has created tailwinds for TSMC. The foundry leader has an illustrious customer base, including Apple, AMD and Nvidia, that looks to apply cutting-edge process technologies to its semiconductor designs.

Read more on TSM